1YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
AT9283 | AT9283 | 896466-04-9 |
evobrutinib | 埃沃布鲁替尼 | 1415823-73-2 |
2,3-CGAMP | 2,3-CGAMP | 1441190-66-4 |
BMS-1001 | BMS-1001 | 2113650-03-4 |
KEA1-97 | KEA1-97 | 2138882-71-8 |
JAK3-IN-6 | JAK3-IN-6 | 1443235-95-7 |
BCH001 | BCH001 | 384859-58-9 |
GSK2643943A | GSK2643943A | 2449301-27-1 |
Acetamide, N-[7-[(3R)-3-[[5-chloro-4-[[2-[(1-methylethyl)sulfonyl]phenyl]amino]-2-pyrimidinyl]amino]-1-piperidinyl]heptyl]-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- | 化合物BSJ-4-116 | 2519823-34-6 |
DIBENZAZEPINE | 二苯并氮卓 | 209984-56-5 |
SEA0400 | 2-[4-[(2,5-二氟苯基)甲氧基]苯氧基]-5-乙氧基苯胺 | 223104-29-8 |
R1487 | SY-R1487 | 449808-64-4 |
KHS 101 | KHS101 | 1262770-73-9 |
FAUC 365 | FAUC-365 | 474432-66-1 |
IOX4 | TERT-BUTYL 6-(5-OXO-4-(1H-1,2,3-TRIAZOL-1-YL)-2,5-DIHYDRO-1H-PYRAZOL-1-YL)NICOTINATE | 1154097-71-8 |
CAY10594 | CAY10594 | 1130067-34-3 |
Sobetirome | SOBETIROME | 211110-63-3 |
bis-2-(5-PhenylacetMido-1,2,4-Thiadiazol-2-yl)Ethyl Sulfide | BPTES | 314045-39-1 |
SAR-20347 | CPDD1211 | 1450881-55-6 |
Ibiglustat | GENZ-682452 | 1401090-53-6 |
PubChem ID: 397887 | LMP744; LMP-744; LMP 744; MJ-III-65; NSC-706744 | 308246-57-3 |
BMS-1166 | BMS-1166 | 1818314-88-3 |
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 7-[5-[(aminosulfonyl)amino]-5-deoxy-β-D-ribofuranosyl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]- | TAS4464 | 1848959-10-3 |
Amonafide | 氨萘非特 | 69408-81-7 |
FASUDIL | 法舒地尔 | 103745-39-7 |
Elesclomol | 伊利司莫 Elesclomol | 488832-69-5 |
HG-9-91-01 | N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲 | 1456858-58-4 |
TNU9056 | NU 9056 | 1450644-28-6 |
Uprosertib | TP0463518 | 1558021-37-0 |
UNC2541 | UNC2541 | 1612782-86-1 |
Uridine 5'-diphosphoglucose disodium salt | 二磷酸尿苷葡萄糖二钠盐 | 28053-08-9 |
BIX 01294, 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine hydrate trihydrochloride | BIX 01294 | 935693-62-2 |
PD-166866 | PD-166866 | 192705-79-6 |
Quisinostat | JNJ 26854165 | 875320-29-9 |
HG-10-102-01 | [4-[[5-氯-4-(甲基氨基)-2-嘧啶基]氨基]-3-甲氧基苯基]-4-吗啉基甲酮 | 1351758-81-0 |
GSK2141795 | UPROSERTIB | 1047634-65-0 |
TBK1/IKKε-IN-2 | CS-1801 | 1292310-49-6 |
EPZ031686 | CS-2707 | 1808011-22-4 |
MELK-8a hydrochloride | MELK-8a | 1922153-17-0 |
BLU-782 | BLU-782 | 2141955-96-4 |
SNDX-5613 | SNDX-5613 | 2169919-21-3 |
Desciclovir | 地昔洛韦 | 84408-37-7 |
Bafetinib | 巴非替尼 | 887650-05-7 |
APY29 | APY29 | 1216665-49-4 |
CDK7-IN-1 | THZ2 | 1604810-84-5 |
GDC0575 monohydrochloride | GDC0575 HYDROCHLORIDE | 1196504-54-7 |
PF-06260933 | 化合物PF6260933 | 1811510-56-1 |
VH-032 | VH-032 | 1448188-62-2 |
ZT-12-037-01 | ZT-12-037-01 | 2328073-61-4 |
2-DIETHYLAMINOETHYL 1-(4-NITROPHENYL)CYCLOPENTANECARBOXYLATE HYDROCHLORIDE | 化合物NITROCARAMIPHEN HYDROCHLORIDE | 98636-73-8 |
Acetamide, 2-chloro-N-(2,2-dimethylpropyl)-N-(tetrahydro-1,1-dioxido-3-thienyl)- | Acetamide, 2-chloro-N-(2,2-dimethylpropyl)-N-(tetrahydro-1,1-dioxido-3-thienyl)- | 2451481-08-4 |
Guanoclor | 胍氯酚 | 5001-32-1 |
E7820 | CS-2701 | 289483-69-8 |
Etalocib | Etalocib | 161172-51-6 |
N-[6-(2,6-Dichlorophenyl)-2-[[4-(diethylamino)butyl]amino]pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)urea | PD-161570;PF-1480232 | 192705-80-9 |
HA130 | HA 130,自分泌运动抑制剂 | 1229652-21-4 |
FH 535 | 2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺 | 108409-83-2 |
OT-R antagonist 1 | 化合物 T12331L | 364071-17-0 |
INCB8761(PF-4136309) | INCB8761(PF-4136309) | 1341224-83-6 |
URMC-099 | URMC-099 | 1229582-33-5 |
BCI | BCI | 1245792-51-1 |
KO-947 | KO-947 | 1695533-89-1 |
FM381 | (E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE | 2226521-65-7 |
Sotorasib | AMG510 单一构型 | 2296729-00-3 |
ZZW-115 hydrochloride | ZZW-115 hydrochloride | 10122-45-9 |
Tasisulam | 他斯索兰 | 519055-62-0 |
Tepotinib | 特泊替尼 | 1100598-32-0 |
SC 144 | 吡嗪羧酸 2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼 | 895158-95-9 |
5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | PI3K/MTOR抑制剂 | 1225037-39-7 |
Ezutromid | 依珠曲米 | 945531-77-1 |
SGC2085 | SGC2085 | 1821908-48-8 |
INARIGIVIR SOPROXIL | INARIGIVIR SOPROXIL | 942123-43-5 |
ethyl 4-((4-(diethylamino)phenyl)imino)-6-methyl-1,4-dihydroquinoline-3-carboxylate | MCU i4 | 371924-24-2 |
BP 897 | N-[4-[4-(2-甲氧基苯基)-1-哌嗪基]丁基]-2-萘甲酰胺单盐酸盐 | 314776-92-6 |
VTP50469 | VTP50469 | 2169916-18-9 |
IPN-60090 | IPN-60090 | 1853164-83-6 |
1,4,8-Triazaspiro[4.5]decan-2-one, 8-methyl-1-(phenylmethyl)- | 1-苄基-8-甲基-1,4,8-三氮杂螺[4.5]癸烷-2-酮 | 1224591-33-6 |
Pirmenol | Pirmenol | 68252-19-7 |
4SC-202 | 4SC-202(盐的形式) | 1186222-89-8 |
AX20017 | AX 20017 | 329221-38-7 |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-dichlorophenyl)-8-ethyl-2-[[3-fluoro-4-(1-piperazinyl)phenyl]aMino]- | FRAX486 | 1232030-35-1 |
LY 2606368 | 5-[[5-[2-(3-氨基丙氧基)-6-甲氧基苯基]-1H-吡唑-3-基]氨基]-2-吡嗪甲腈 | 1234015-52-1 |
HG-14-10-04 | CS-1175 | 1356962-34-9 |
Olmutinib | 奥莫替尼 | 1353550-13-6 |
(R)-N-(4-(3-aminopiperidin-1-yl)-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)cyclopropanecarboxamide | (R)-N-(4-(3-氨基哌啶-1-基)-5-溴-1H-吡咯并[2,3-B]吡啶-3-基)环丙烷甲酰胺 | 1196541-47-5 |
NCT-503 | NCT503 | 1916571-90-8 |
BTK IN-1 | SNS062 | 1270014-40-8 |
Autophinib | 6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE | 1644443-47-9 |
MRTX1133 | MRTX1133 | 2621928-55-8 |
Idalopirdine | LU AE58054 | 467459-31-0 |
SC75741 | SC75741 | 913822-46-5 |
SAR131675 | SAR131675 | 1433953-83-3 |
BIX 01294 | BIX 01294三盐酸盐水合物 | 1392399-03-9 |
Entospletinib (GS-9973) | GS-9973 | 1229208-44-9 |
UNC0379 | UNC0379 | 1620401-82-2 |
NVP-BAW2881 | BAW2881 | 861875-60-7 |
BMS-1166 HCl | BMS-1166 HCl | 2113650-05-6 |
PD 173074 | PD173074 | 219580-11-7 |
GSK8612 | GSK8612 | 2361659-62-1 |
BMS-1001 hydrochloride | BMS-1001 | 2113650-04-5 |
联系方式